Pain: Morphine, metabolites, mambas, and mutations

The Lancet Neurology

Volumn 12, Issue 1, 2013, Pages 18-20

  Woolf, Clifford J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; SODIUM CHANNEL NAV1.7;

ANALGESIA; CRYSTAL STRUCTURE; GAIN OF FUNCTION MUTATION; GENE MUTATION; HUMAN; METABOLITE; NEUROPATHIC PAIN; NONHUMAN; NOTE; PAIN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; COBRA VENOMS; ELAPIDAE; HUMANS; MORPHINE; MUTATION; PAIN;

EID: 84870794908     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70287-9     Document Type: Note

References (8)

1. Manglik A, Kruse AC, Kobilka TS, et al. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 2012, 485:321-326.
2. Bierhaus A, Fleming T, Stoyanov S, et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012, 18:926-933.
3. Diochot S, Baron A, Salinas M, et al. Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature 2012, 490:552-555.
4. Woolf CJ, Mannion RJ Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964.
5. Bráz JM, Sharif-Naeini R, Vogt D, et al. Forebrain GABAergic neuron precursors integrate into adult spinal cord and reduce injury-induced neuropathic pain. Neuron 2012, 74:663-675.
6. Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012, 71:26-39.
7. Chambers SM, Qi Y, Mica Y, et al. Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol 2012, 30:715-720.
8. Baliki MN, Petre B, Torbey S, et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci 2012, 15:1117-1119.